|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/705 | |
| A61K 38/17 | |||
| A61P 19/00 | |||
| A61P 21/00 | |||
| A61P 25/00 |
| (11) | Patento numeris | 1771470 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05775451.7 |
| Europos patento paraiškos padavimo data | 2005-07-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-06-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/026368 |
| Data | 2005-07-25 |
| (87) | Numeris | WO 2006/012627 |
| Data | 2006-02-02 |
| (30) | Numeris | Data | Šalis |
| 590765 P | 2004-07-23 | US |
| (72) |
KNOPF, John, US
SEEHRA, Jasbir, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTRII RECEPTOR POLYPEPTIDES, METHODS AND COMPOSITIONS |
| ACTRII RECEPTOR POLYPEPTIDES, METHODS AND COMPOSITIONS |